Nuvation Bio Inc. (NUVB-WT)

USD 0.16

(0.65%)

Operating Expenses Summary of Nuvation Bio Inc.

  • Nuvation Bio Inc.'s latest annual operating expenses in 2023 was 99.82 Million USD , down -16.63% from previous year.
  • Nuvation Bio Inc.'s latest quarterly operating expenses in 2024 Q2 was 45.15 Million USD , up 124.21% from previous quarter.
  • Nuvation Bio Inc. reported a annual operating expenses of 119.73 Million USD in annual operating expenses 2022, up 28.31% from previous year.
  • Nuvation Bio Inc. reported a annual operating expenses of 93.31 Million USD in annual operating expenses 2021, up 114.27% from previous year.
  • Nuvation Bio Inc. reported a quarterly operating expenses of 45.15 Million USD for 2024 Q2, up 124.21% from previous quarter.
  • Nuvation Bio Inc. reported a quarterly operating expenses of 26.13 Million USD for 2023 Q2, down -1.47% from previous quarter.

Annual Operating Expenses Chart of Nuvation Bio Inc. (2023 - 2018)

Historical Annual Operating Expenses of Nuvation Bio Inc. (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 99.82 Million USD -16.63%
2022 119.73 Million USD 28.31%
2021 93.31 Million USD 114.27%
2020 43.55 Million USD 35.33%
2019 32.18 Million USD 3144.05%
2018 992 Thousand USD 0.0%

Peer Operating Expenses Comparison of Nuvation Bio Inc.

Name Operating Expenses Operating Expenses Difference
ADC Therapeutics SA 233.01 Million USD 57.161%
Alto Neuroscience, Inc. 37.8 Million USD -164.017%
Annovis Bio, Inc. 45.03 Million USD -121.654%
Biohaven Pharmaceutical Holding Company Ltd. 436.05 Million USD 77.108%
Ginkgo Bioworks Holdings, Inc. 1.1 Billion USD 90.994%
Nuvation Bio Inc. 99.82 Million USD 0.0%
Arcus Biosciences, Inc. 457 Million USD 78.157%
Theriva Biologics, Inc. 21.43 Million USD -365.783%
Zymeworks Inc. 196.76 Million USD 49.267%